Calprotectin: from biomarker to biological function
The incidence of inflammatory bowel diseases (IBD) emerged with Westernisation of dietary
habits worldwide. Crohn's disease and ulcerative colitis are chronic debilitating conditions …
habits worldwide. Crohn's disease and ulcerative colitis are chronic debilitating conditions …
Biomarkers in IBD: What to Utilize for the Diagnosis?
R D'Incà, G Sturniolo - Diagnostics, 2023 - mdpi.com
The role of biomarkers in the diagnosis of inflammatory bowel disease is not fully
characterized. C-reactive protein has a short half-life and elevates quickly after the onset of …
characterized. C-reactive protein has a short half-life and elevates quickly after the onset of …
Increased intestinal permeability and stool zonulin, calprotectin and beta-defensin-2 concentrations in allogenic hematopoietic cell transplantation recipients
M Tyszka, D Maciejewska-Markiewicz… - International Journal of …, 2022 - mdpi.com
Significant progress has been made in understanding the connection between intestinal
barrier function and allogenic hematopoietic cell transplantation (allo-HCT) recipients' …
barrier function and allogenic hematopoietic cell transplantation (allo-HCT) recipients' …
Fecal calprotectin is elevated in HIV and related to systemic inflammation
AR Eckard, HY Hughes, NL Hagood… - JAIDS Journal of …, 2021 - journals.lww.com
Background: Fecal calprotectin (FC), a biomarker of gastrointestinal (GI) inflammation, is
used in the diagnosis and management of inflammatory bowel disease. HIV infection …
used in the diagnosis and management of inflammatory bowel disease. HIV infection …
Biomarkers in inflammatory bowel disease: a practical guide
J Clough, M Colwill, A Poullis, R Pollok… - Therapeutic …, 2024 - journals.sagepub.com
Inflammatory bowel disease (IBD), comprising ulcerative colitis (UC) and Crohn's disease
(CD), is a costly condition in terms of morbidity and healthcare utilization, with an increasing …
(CD), is a costly condition in terms of morbidity and healthcare utilization, with an increasing …
A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant
S Ramalingam, S Siamakpour-Reihani, L Bohannan… - Plos one, 2021 - journals.plos.org
Background Allogeneic hematopoietic stem cell transplantation (HCT) is an often curative
intent treatment, however it is associated with significant gastrointestinal (GI) toxicity and …
intent treatment, however it is associated with significant gastrointestinal (GI) toxicity and …
[HTML][HTML] Pancytopenia in a patient with Stevens-Johnson syndrome: A case report with literature review
MN Malik, AM Ullah, ME Ahmad, R Riaz, TIS Syed - Cureus, 2019 - ncbi.nlm.nih.gov
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare conditions
triggered due to a medication that involves the necrosis and desquamation of the skin and …
triggered due to a medication that involves the necrosis and desquamation of the skin and …
Diagnostic, prophylaxie et prise en charge thérapeutique de la GVH aiguë: recommandations de la SFGM-TC
L Souchet, S Masouridi, A Marçais, A Ibrahim… - Bulletin du …, 2023 - Elsevier
Résumé La GVH aiguë est une complication potentiellement sévère de l'allogreffe de
cellules souches hématopoïétiques, responsable d'une morbidité et d'une mortalité pouvant …
cellules souches hématopoïétiques, responsable d'une morbidité et d'une mortalité pouvant …
[HTML][HTML] Клинико-сонографические параллели гастроэзофагеальной рефлюксной болезни и коморбидной гастроинтестинальной патологии
ВВ Горбань, ЭВ Матвеева, ЕВ Горбань - Медицинский совет, 2022 - cyberleninka.ru
Введение. Рост сочетанных с гастроэзофагеальной рефлюксной болезнью (ГЭРБ)
заболеваний диктует необходимость разработки методических подходов для ранней …
заболеваний диктует необходимость разработки методических подходов для ранней …